These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6779765)

  • 41. Impairment of myocardial function induced by particulate contamination of cardioplegic solutions.
    Robinson LA; Braimbridge MV; Hearse DJ
    Adv Myocardiol; 1985; 6():503-12. PubMed ID: 3992048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary evaluation of cocarboxylase on myocardial protection of the rat heart.
    Larrieu AJ; Kao RL; Yazdanfar S; Redovan E; Silver J; Ghosh S; Magovern GJ
    Ann Thorac Surg; 1987 Feb; 43(2):168-71. PubMed ID: 3813706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardioplegia.
    Hearse DJ
    Postgrad Med J; 1983; 59 Suppl 2():11-24. PubMed ID: 6351042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myocardial protection in pediatric cardiac surgery.
    Turkoz R
    Artif Organs; 2013 Jan; 37(1):16-20. PubMed ID: 23305570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ionic bases of cardioplegic solutions. I. Some implications of the role of ionic equilibrium in the preservation of cardiac metabolism. Experimental study of hypoxia and calcium overloads].
    Ventura-Clapier R; Vassort G
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1456-64. PubMed ID: 6322714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardioplegic arrest in isolated blood-perfused working rat hearts.
    Hendriks FF; Jonas J; van der Laarse A; Huysmans HA
    J Surg Res; 1983 Jul; 35(1):41-9. PubMed ID: 6865392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and experimental study of cold cardioplegic myocardial protection.
    Szabó Z; Juhász-Nagy A; Lengyel I; Moravcsik E; Papp L
    Cor Vasa; 1984; 26(5):336-44. PubMed ID: 6509990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial protection with blood cardioplegia in ischemically injured hearts: reduction of reoxygenation injury with allopurinol.
    Vinten-Johansen J; Chiantella V; Faust KB; Johnston WE; McCain BL; Hartman M; Mills SA; Hester TO; Cordell AR
    Ann Thorac Surg; 1988 Mar; 45(3):319-26. PubMed ID: 3348704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of allopurinol on myocardial recovery during reperfusion.
    Soncul H; Gökgöz L; Kalaycioglu S; Sinci V; Kaptanoglu M; Ersöz A
    Scand J Clin Lab Invest; 1993 Feb; 53(1):11-5. PubMed ID: 8451598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-ischemic myocardial function after pre-ischemic application of propranolol or verapamil.
    Preusse CJ; Gebhard MM; Schnabel A; Ulbricht LJ; Bretschneider HJ
    J Cardiovasc Surg (Torino); 1984; 25(2):158-64. PubMed ID: 6725387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of Ryanodine for the myocardial protection in the working heart model of rabbit].
    Morita M; Sakai Y; Hikita Y; Sawada Y; Minohara S; Oku T; Sasaki S; Takeuchi A; Nakagaki I; Sasaki S
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Jan; 41(1):22-6. PubMed ID: 8459141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myocardial protection during repair of congenital heart disease in infants (author's transl)].
    Frigiola A; Menicanti L; Belloli JP; Bedogni L; Facin G
    Chir Pediatr; 1980; 21(1):15-8. PubMed ID: 6773679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocardial protection during cardioplegia in open-heart surgery: a review.
    Chatrath RR; Kaul TK; Walker DR
    Can Anaesth Soc J; 1980 Jul; 27(4):381-8. PubMed ID: 6996794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic myocardial protection with allopurinol during cardiopulmonary bypass and aortic cross-clamping.
    Lindsay WG; Toledo-Pereyra LH; Foker JE; Varco RL
    Surg Forum; 1975; 26():259-60. PubMed ID: 1216130
    [No Abstract]   [Full Text] [Related]  

  • 55. Experimental study of the effects of sodium ion concentrations on the function of the myocardium exposed to cardioplegic ischemia.
    Bokeriya LA; Boldyrev AA; Movsesyan RR; Kulaga OI; Bledzhyants GA; Egorov DN; Popov AE; Plyushch MG; Kozar EF; Kalaeva NV
    Bull Exp Biol Med; 2014 Apr; 156(6):880-4. PubMed ID: 24824721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experimental heart transplantation: acute hemodynamic evaluation comparing 2 different methods of myocardial protection].
    Bonnin JO; Arís A; Montesinos A; Caralps JM
    Rev Esp Cardiol; 1987; 40 Suppl 2():25-30. PubMed ID: 3331800
    [No Abstract]   [Full Text] [Related]  

  • 57. The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: the protective effect of orotic acid.
    Munsch C; Williams JF; Rosenfeldt FL
    J Mol Cell Cardiol; 1989 Aug; 21(8):751-4. PubMed ID: 2778812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic effects of mexiletine and disopyramide after cardioplegic arrest.
    Moritz A; Eckersberger F; Losert U; Probst P; Schreiner W; Wolner E
    Eur Surg Res; 1989; 21(6):327-35. PubMed ID: 2633930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Phosphocreatine in the protection of the myocardium in cardioplegic arrest; biochemical and functional aspects in the dog].
    Bricco G; Piacenza G; Borgoglio R; Zamperone O; Sguazzi P
    Cardiologia; 1986 Jul; 31(7):509-14. PubMed ID: 3568043
    [No Abstract]   [Full Text] [Related]  

  • 60. Functional and metabolic effects of cardioplegia induced by a young's solution (YNG solution) as assessed in isolated atrial preparations and in isolated perfused heart preparations of the guinea pig.
    Kawada T; Shimomura H; Kajiwara Y; Yoshida S; Imai S
    Jpn Heart J; 1984 Mar; 25(2):207-18. PubMed ID: 6748221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.